Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04502095 · ClinicalTrials.gov registry record · Phase 4
Prophylactic Antibiotics for Urinary Tract Infections After Robot-Assisted Radical Cystectomy
A Phase 4 study, sponsored by Roswell Park Cancer Institute.
- Completed
- Registry status
- Phase 4
- Development phase
- 89
- Enrollment target
NCT04502095: Completed Phase 4 study, sponsored by Roswell Park Cancer Institute.
NCT04502095 is a Phase 4 study that has completed, run by Roswell Park Cancer Institute. The registered enrollment target is 89 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04502095, a Phase 4 study, has completed, sponsored by Roswell Park Cancer Institute.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 89 participants
- Enrollment target
Study Summary
This trial investigates whether a one-month course of preventative (prophylactic) antibiotics helps to reduce urinary tract infections after robot-assisted surgery to remove all of the bladder as well as nearby tissues and organs (radical cystectomy). Urinary tract infections are a common occurrence after robot-assisted radical cystectomy. Antibiotics such as trimethoprim-sulfamethoxazole or nitrofurantoin may prevent or control infections in patients with urinary tract infection and may help improve their response to radical cystectomy. Information gained from this study may help researchers to predict patient complications and identify better ways to manage these complications.
Primary Outcome
Will be treated as dichotomous data and will be summarized by group using frequencies and relative frequencies.
Interventions
- DRUG Clindamycin
- DRUG Nitrofurantoin
- DRUG Levofloxacin
- OTHER Diary
- DRUG Ertapenem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 89 participants |
| Start Date | 2020-09-02 |
| Est. Completion | 2025-03-13 |
| Phase | Phase 4 |
What the finished NCT04502095 record still lists
NCT04502095 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 89 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (83% lower).
The record links to 0 conditions, and to 5 interventions - of which Clindamycin is the first listed.
NCT04502095 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04502095 about?
NCT04502095 is a clinical study titled "Prophylactic Antibiotics for Urinary Tract Infections After Robot-Assisted Radical Cystectomy". This trial investigates whether a one-month course of preventative (prophylactic) antibiotics helps to reduce urinary tract infections after robot-assisted surgery to remove all of the bladder as well as nearby tissues and organs (radical cystectomy). Urinary tract infections are a common occurrence...
What is the current status of trial NCT04502095?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 89 participants. The study started on 2020-09-02. Estimated completion is 2025-03-13.
What interventions are being tested in trial NCT04502095?
The interventions under investigation include: Clindamycin (DRUG), Nitrofurantoin (DRUG), Levofloxacin (DRUG), Diary (OTHER), Ertapenem (DRUG).
Who is sponsoring clinical trial NCT04502095?
This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04502095's enrollment target sits among peer trials
89 913th of 2000 higher than 1,085 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03682289 · 89 participants · Phase 2
Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors
- NCT04787939 · 89 participants · NA
Early Feeding After Oral Cavity Reconstruction
- NCT05480449 · 89 participants · Phase 1
Autologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform for Pediatric B-ALL (huCART19 Prodigy)
- NCT05604131 · 89 participants · Phase 2
Cardiac MRI-guided Deferiprone Therapy for Acute Myocardial Infarction Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI